Glatiramer Acetate Label Update: Medication Errors With Incompatible Autoinjectors
Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis.
Stay updated with breaking news from Acetate Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis.
The product will be manufactured at Lupin’s Nagpur facility in India.
Mumbai, Baltimore, November 17, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its...
Mylan Institutional has voluntarily recalled Octreotide Acetate Inj, 500mcg/mL at the user level due to the presence of glass particles in a syringe.
The FDA has issued a safety communication regarding cross-compatibility issues with autoinjector devices that are optional for use with glatiramer acetate injection.